Revolution Medicines Wins FDA Approval for Pancreatic Cancer Pill. What It Means for the Stock.

Daraxonrasib, the pill touted by a former member of Congress and cancer patient as a ‘miracle drug,' has been granted approval in patients with pancreatic adenocarcinoma.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。